The development of biomarkers for degenerative musculoskeletal conditions

Discovery Medicine

Volumn 17, Issue 92, 2014, Pages 59-66

  Jayabalan, Prakash ^a   Sowa, Gwendolyn A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AGGRECANASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBOXY TERMINAL TELOPEPTIDE; CARTILAGE OLIGOMER MATRIX PROTEIN; CHONDROITIN SULFATE; COLLAGEN TYPE 2; COMPLEMENT MEMBRANE ATTACK COMPLEX; GLUCOSAMINE; HYALURONIC ACID; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; KERATAN SULFATE; LEPTIN; LICOFELONE; NAPROXEN; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; PROSTAGLANDIN E2; PYRIDINOLINE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AGING; ARTICLE; BIOLOGICAL THERAPY; BLOOD ANALYSIS; CARTILAGE; DEGENERATIVE DISEASE; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; INFLAMMATION; INTERVENTION STUDY; META ANALYSIS (TOPIC); METABOLITE; MUSCLE METABOLISM; MUSCULOSKELETAL DISEASE; MUSCULOSKELETAL PAIN; MUSCULOSKELETAL STIFFNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OSTEOARTHRITIS; PERSONALIZED MEDICINE; PHASE 3 CLINICAL TRIAL (TOPIC); PROGNOSIS; REHABILITATION MEDICINE; SYNOVIUM; THERAPY EFFECT; TISSUE DEGENERATION; TISSUE INJURY; URINALYSIS;

BIOLOGICAL MARKERS; HUMANS; MUSCULOSKELETAL DISEASES; PROGNOSIS; TREATMENT OUTCOME;

EID: 84894470215     PISSN: 15396509     EISSN: 19447930     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Atkinson AJ Jr, Colburn WA, Degruttola VG, Demets DL, Downing GJ, Hoth DF, Oates JA, Peck CC, Schooley RT, Spilker BA, Woodcock J, Zeger SL. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89-95, 2001.
2. Bay-Jensen AC, Liu Q, Byrjalsen I, Li Y, Wang J, Pedersen C, Leeming DJ, Dam EB, Zheng Q, Qvist P, Karsdal MA. Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM-Increased serum CIIM in subjects with severe radiographic osteoarthritis. Clin Biochem 44(5-6):423-429, 2011.
3. Cibere J, Zhang H, Garnero P, Poole AR, Lobanok T, Saxne T, Kraus VB, Way A, Thorne A, Wong H, Singer J, Kopec J, Guermazi A, Peterfy C, Nicolaou S, Munk PL, Esdaile JM. Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. Arthritis Rheum 60(5):1372-1380, 2009.
4. Conrozier T, Balblanc JC, Richette P, Mulleman D, Maillet B, Henrotin Y, Rannou F, Piroth C, Hilliquin P, Mathieu P, Walliser-Lohse A, Rousselot I, Plattner V, Maillefert JF, Vignon E, Chevalier X. Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open-label observational prospective study. J Orthop Res 30(5):679-685, 2012.
5. Creamer P. Osteoarthritis pain and its treatment. Curr Opin Rheumatol 12(5):450-455, 2000.
6. Dam EB, Byrjalsen I, Karsdal MA, Qvist P, Christiansen C. Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI. Osteoarthritis Cartilage 17(3):384-389, 2009.
7. Dragomir AD, Kraus VB, Renner JB, Luta G, Clark A, Vilim V, Hochberg MC, Helmick CG, Jordan JM. Serum cartilage oligomeric matrix protein and clinical signs and symptoms of potential pre-radiographic hip and knee pathology. Osteoarthritis Cartilage 10(9):687-691, 2002.
8. Elliott AL, Kraus VB, Luta G, Stabler T, Renner JB, Woodard J, Dragomir AD, Helmick CG, Hochberg MC, Jordan JM. Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and caucasians in the Johnston County Osteoarthritis Project. Arthritis Rheum 52(1):105-111, 2005.
9. Fraenkel L, RoubenoffR, Lavalley M, Mcalindon T, Chaisson C, Evans S, Harris T, Dinarello CA, Felson DT. The association of peripheral monocyte derived interleukin 1β (IL- 1β), IL-1 receptor antagonist, and tumor necrosis factor-α with osteoarthritis in the elderly. J Rheumatol 25(9):1820-1826, 1998.
10. Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: Relations with disease activity and joint damage. Ann Rheum Dis 60(6):619-626, 2001.
11. Gineyts E, Mo JA, Ko A, Henriksen DB, Curtis SP, Gertz BJ, Garnero P, Delmas PD. Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis synovium turnover in patients with osteoarthritis. Ann Rheum Dis 63(7):857-861, 2004.
12. Golightly YM, Marshall SW, Kraus VB, Renner JB, Villaveces A, Casteel C, Jordan JM. Biomarkers of incident radiographic knee osteoarthritis: Do they vary by chronic knee symptoms? Arthritis Rheum 63(8):2276-2283, 2011.
13. Grotle M, Hagen KB, Natvig B, Dahl FA, Kvien TK. Obesity and osteoarthritis in knee, hip and/or hand: An epidemiological study in the general population with 10 years follow-up. BMC Musculoskelet Disord 9:132, 2008.
14. Guermazi A, Roemer FW, Burstein D, Hayashi D. Why radiography should no longer be considered a surrogate outcome measure for longitudinal assessment of cartilage in knee osteoarthritis. Arthritis Res Ther 13(6):247, 2011.
15. Hoch JM, Mattacola CG, Medina Mckeon JM, Howard JS, Lattermann C. Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: A systematic review and meta-analysis. Osteoarthritis Cartilage 19(12):1396-1404, 2011.
16. Hutchinson MR. The Burden of Musculoskeletal Diseases in the United States: Prevalance, Societal and Economic Cost, 1st Edition. J Am Coll Surg 208(1):e5-e6, 2009.
17. Jayabalan P, Stoker AM, Sayers SP, Cook JL. The Development of A Biomarker Panel for the Rehabilitation of Osteoarthritis. Am J Phys Med Rehab 92(3):283, 2013.
18. Kang JD, Stefanovic-Racic M, Mcintyre LA, Georgescu HI, Evans CH. Toward a biochemical understanding of human intervertebral disc degeneration and herniation: Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases. Spine 22(10):1065-1073, 1997.
19. Kersting UG, StubendorffJJ, Schmidt MC, Brüggemann GP. Changes in knee cartilage volume and serum COMP concentration after running exercise. Osteoarthritis Cartilage 13(10):925-934, 2005.
20. Kong SY, Stabler TV, Criscione LG, Elliott AL, Jordan JM, Kraus VB. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. Arthritis Rheum 54(8):2496-2504, 2006.
21. Lago R, Gomez R, Otero M, Lago F, Gallego R, Dieguez C, Gomez-Reino JJ, Gualillo O. A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthritis Cartilage 16(9):1101-1109, 2008.
22. Martel-Pelletier J, Lajeunesse D, Reboul P, Pelletier JP. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis 62(6):501-509, 2003.
23. Mazières B, Hucher M, Zaïm M, Garnero P. Effect of chondroitin sulphate in symptomatic knee osteoarthritis: A multicentre, randomised, double-blind, placebo-controlled study. Ann Rheum Dis 66(5):639-645, 2007.
24. Mcnulty AL, Miller MR, O'connor SK, Guilak F. The effects of adipokines on cartilage and meniscus catabolism. Connect Tissue Res 52(6):523-533, 2011.
25. Meulenbelt I, Kloppenburg M, Kroon HM, Houwing-Duistermaat JJ, Garnero P, Hellio Le Graverand MP, Degroot J, Slagboom PE. Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: The GARP study. Ann Rheum Dis 65(3):360-365, 2006.
26. Mündermann A, King KB, Smith RL, Andriacchi TP. Change in serum COMP concentration due to ambulatory load is not related to knee OA status. J Orthop Res 27(11):1408-1413, 2009.
27. Naito K, Watari T, Furuhata A, Yomogida S, Sakamoto K, Kurosawa H, Kaneko K, Nagaoka I. Evaluation of the effect of glucosamine on an experimental rat osteoarthritis model. Life Sci 86(13-14):538-543, 2010.
28. Ormos G, Mehrishi JN, Bakács T. Reduction in high blood tumor necrosis factor-α levels after manipulative therapy in 2 cervicogenic headache patients. J Manipulative Physiol Ther 32(7):586-591, 2009.
29. Pelletier JP, Raynauld JP, Caron J, Mineau F, Abram F, Dorais M, Haraoui B, Choquette D, Martel-Pelletier J. Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis. Ann Rheum Dis 69(12):2095-2101, 2010.
30. Reginster JY, Neuprez A, Lecart MP, Sarlet N, Bruyere O. Role of glucosamine in the treatment for osteoarthritis. Rheumatol Int 32(10):2959-2967, 2012.
31. Reijman M, Hazes JMW, Bierma-Zeinstra SMA, Koes BW, Christgau S, Christiansen C, Uitterlinden AG, Pols HaP. A new marker for osteoarthritis: Cross-sectional and longitudinal approach. Arthritis Rheum 50(8):2471-2478, 2004.
32. Rizkalla G, Reiner A, Bogoch E, Poole AR. Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis: Evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest 90(6):2268-2277, 1992.
33. Shin KA, Kim AC, Kim YJ, Lee YH, Shin YO, Kim SH, Park YS, Nam HS, Kim T, Kim HS, Park Y. Effect of ultra-marathon (308 km) race on bone metabolism and cartilage damage biomarkers. Ann Rehab Med 36(1):80-87, 2012.
34. Sowa G, Westrick E, Rajasekhar AG, Woods B, Leckie S, Coelho P, Vo N, Studer R, Kang J. Identification of candidate serum biomarkers for intervertebral disk degeneration in an animal model. PM R 1(6):536-540, 2009.
35. Staikos C, Ververidis A, Drosos G, Manolopoulos VG, Verettas DA, Tavridou A. The association of adipokine levels in plasma and synovial fluid with the severity of knee osteoarthritis. Rheumatology (Oxford) 52(6):1077-1083, 2013.
36. Stannus O, Jones G, Cicuttini F, Parameswaran V, Quinn S, Burgess J, Ding C. Circulating levels of IL-6 and TNF-α are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthritis Cartilage 18(11):1441-1447, 2010.
37. Wakitani S, Nawata M, Kawaguchi A, Okabe T, Takaoka K, Tsuchiya T, Nakaoka R, Masuda H, Miyazaki K. Serum keratan sulfate is a promising marker of early articular cartilage breakdown. Rheumatology (Oxford) 46(11):1652-1656, 2007.
38. Wakitani S, Okabe T, Kawaguchi A, Nawata M, Hashimoto Y. Highly sensitive ELISA for determining serum keratan sulphate levels in the diagnosis of OA. Rheumatology (Oxford) 49(1):57-62, 2010.
39. Wang Q, Rozelle AL, Lepus CM, Scanzello CR, Song JJ, Larsen DM, Crish JF, Bebek G, Ritter SY, Lindstrom TM, Hwang I, Wong HH, Punzi L, Encarnacion A, Shamloo M, Goodman SB, Wyss-Coray T, Goldring SR, Banda NK, Thurman JM, et al. Identification of a central role for complement in osteoarthritis. Nat Med 17(12):1674-1679, 2011.
40. Xu HT, Chen Y, Chen LK, Li JY, Zhang W, Wu B. Effect of various intervention factors on MMP-3 and TIMP-1 level in synovial fluid in knee joints with osteoarthritis. Zhong Nan Da Xue Xue Bao Yi Xue Ban 33(1):47-52, 2008.
41. Yasui T, Akatsuka M, Tobetto K, Umemoto J, Ando T, Yamashita K, Hayakawa T. Effects of hyaluronan on the production of stromelysin and tissue inhibitor of metalloproteinase-1 (TIMP-1) in bovine articular chondrocytes. Biomed Res 13(5):343-348, 1992.
42. Yusuf E, Ioan-Facsinay A, Bijsterbosch J, Klein-Wieringa I, Kwekkeboom J, Slagboom PE, Huizinga TWJ, Kloppenburg M. Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritis. Ann Rheum Dis 70(7):1282-1284, 2011